![](/img/cover-not-exists.png)
PSS3 INDUCTION COST PER RESPONDER OF BRODALUMAB COMPARED WITH OTHER BIOLOGICS APPROVED FOR PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN CANADA
Gaudet, V., Barbeau, M., Muratov, S., Golden, S., Khoudigian-Sinani, S.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2565
Date:
November, 2019
File:
PDF, 389 KB
2019